General
Preferred name
SULFACYTINE
Synonyms
Sulfacitina ()
Renoquid ()
Sulfacitine ()
CI-636 ()
NSC-356717 ()
P&D ID
PD009917
CAS
1401-49-6
17784-12-2
Tags
available
drug
Approved by
FDA
First approval
1975
Drug indication
Urinary tract infection
Cystitis
Drug Status
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Sulfacytine is a short-acting sulfonamide antibiotic. Sulfacytine is active against bacteria and is an effective agent for the research of acute uncomplicated urinary tract infections[1].
DESCRIPTION
Sulfacytine, a benzenesulfonamide derivative, could be used as an antibiotic through restraining the formation of folate.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
25
Molecular Weight
294.08
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
0.65
TPSA
107.08
Fraction CSP3
0.17
Chiral centers
0.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
ATC
G01AE10
Target
antibiotic
Bacterial
Therapeutic Class
Antiinfective Agents
Pathway
Anti-infection
Source data
